InMed Pharmaceuticals Inc. (INM)
Data as of , from SEC Form 4 filings.
See up to 3 months of INM. The 7-day demo opens the 1M and 3M ranges and puts INM on your watchlist.
Start 7-day demoLatest INM insider trades
About InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
- VANCOUVER
- 6
- 2020
- XNAS
INM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 16 | 166,470 | $223K |
INM insider transactions (Form 4)
6531 Form 4 filings on record, the earliest from Dec 23, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 5,601 | $1.33 footnote F1 | $7K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 3,046 | $1.33 | $4K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 2,256 | $1.33 footnote F2 | $3K | |
| ||||||
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 16,431 | $1.33 footnote F1 | $22K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 8,307 | $1.33 | $11K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 18,182 | $1.33 | $24K | |
| ||||||
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 28,505 | $1.29 footnote F1 | $37K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 54,256 | $1.30 footnote F2 | $70K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 8,340 | $1.29 footnote F3 | $11K | |
| ||||||
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 1,000 | $1.56 | $2K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 4,882 | $1.55 | $8K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 493 | $1.55 | $764 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 13,761 | $1.55 | $21K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 1,389 | $1.55 | $2K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 19 | $1.55 | $29 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 2 | $1.55 | $3 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 545 | $1.54 footnote F3 | $839 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 147 | $1.55 footnote F5 | $228 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 55 | $1.54 footnote F3 | $85 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 3,946 | $1.55 footnote F4 | $6K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 398 | $1.55 footnote F4 | $617 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 1,460 | $1.55 footnote F5 | $2K | |
| ||||||
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 3,118 | $1.69 footnote F4 | $5K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 16,164 | $1.57 footnote F5 | $25K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 1,632 | $1.57 footnote F5 | $3K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 14,838 | $1.55 footnote F6 | $23K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 1,498 | $1.55 footnote F6 | $2K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 20,753 | $1.52 footnote F7 | $32K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 2,095 | $1.52 footnote F7 | $3K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 7,069 | $1.55 footnote F8 | $11K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 714 | $1.55 footnote F8 | $1K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 6,125 | $1.57 footnote F9 | $10K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 618 | $1.57 footnote F9 | $970 | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 49,966 | $1.57 footnote F10 | $78K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 5,045 | $1.57 footnote F10 | $8K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 29,518 | $1.52 footnote F11 | $45K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 2,982 | $1.52 footnote F11 | $5K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 51,056 | $1.56 footnote F3 | $80K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 5,154 | $1.56 footnote F3 | $8K | |
| Vivo Opportunity, LLC - 10% Owner | Open-market purchase | Common Shares | 30,882 | $1.69 footnote F4 | $52K | |
| ||||||
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 68,551 | $1.60 footnote F1 | $110K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 200,000 | $1.56 footnote F2 | $312K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Shares | 200,000 | $1.50 footnote F3 | $300K | |
| ||||||
| Shane Aaron Johnson - Officer | Grant or award | Employee Stock Option (Right to Buy) | 8,500 | $0.00 | - | |
| Nicole Lemerond - Director | Grant or award | Employee Stock Option (Right to Buy) | 1,750 | $0.00 | - | |
| Neil A. Klompas - Director | Grant or award | Employee Stock Option (Right to Buy) | 1,750 | $0.00 | - | |
| Netta Jagpal - Officer | Grant or award | Employee Stock Option (Right to Buy) | 18,000 | $0.00 | - | |
| Michael Woudenberg - Officer | Grant or award | Employee Stock Option (Right to Buy) | 18,000 | $0.00 | - | |
| John Steven Bathery - Director | Grant or award | Employee Stock Option (Right to Buy) | 1,750 | $0.00 | - | |
| Eric C. Hsu - Officer | Grant or award | Employee Stock Option (Right to Buy) | 13,000 | $0.00 | - | |
| Eric A. Adams - Officer | Grant or award | Employee Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| Andrew Hull - Director | Grant or award | Employee Stock Option (Right to Buy) | 1,750 | $0.00 | - | |
| Andrew Hull - Director | Other | Employee Stock Option (Expiration) | 14 | $0.00 | - | |
| Eric A. Adams - Officer | Other | Employee Stock Option (Expiration) | 250 | $0.00 | - | |
| Michael Woudenberg - Officer | Other | Employee Stock Option (Expiration) | 60 | $0.00 | - | |
| Eric C. Hsu - Officer | Other | Employee Stock Option (Expiration) | 70 | $0.00 | - | |
| Neil A. Klompas - Director | Grant or award | Employee Stock Option (Right to Buy) | 3,500 | $0.00 | - | |
| Shane Aaron Johnson - Officer | Grant or award | Employee Stock Option (Right to Buy) | 1,500 | $0.00 | - | |
| Netta Jagpal - Officer | Grant or award | Employee Stock Option (Right to Buy) | 3,750 | $0.00 | - | |
| Nicole Lemerond - Director | Grant or award | Employee Stock Option (Right to Buy) | 550 | $0.00 | - | |
| Michael Woudenberg - Officer | Grant or award | Employee Stock Option (Right to Buy) | 3,750 | $0.00 | - | |
| Eric C. Hsu - Officer | Grant or award | Employee Stock Option (Right to Buy) | 2,750 | $0.00 | - | |
| Eric A. Adams - Officer | Grant or award | Employee Stock Option (Right to Buy) | 6,250 | $0.00 | - | |
| Bryan T. Baldasare - Director | Grant or award | Employee Stock Option (Right to Buy) | 550 | $0.00 | - | |
| Andrew Hull - Director | Grant or award | Employee Stock Option (Right to Buy) | 550 | $0.00 | - | |
Item 3.01, 8.01, 9.01
Item 7.01, 8.01, 9.01
Item 1.01, 7.01, 9.01
Item 8.01, 9.01
INM insider trading FAQ
What is the latest insider trade for INM?
InMed Pharmaceuticals Inc. (INM) had 5 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for INM runs to 31 Form 4 filings, the earliest from 2024-12-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying INM stock?
16 insider purchases of INM were filed in the last 90 days, totaling $223K.
How many insiders are selling INM stock?
No insider sales of INM were filed in the last 90 days.
Where can I see INM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects INM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - ADAR1 Capital Management, LLC view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - Vivo Opportunity, LLC view on EDGAR
- - Vivo Opportunity, LLC view on EDGAR
- - Vivo Opportunity, LLC view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - Shane Aaron Johnson view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where INM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow INM with a 7-day demo
- INM on your watchlist
- Every INM Form 4 filing on record
- Up to 3 months of INM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
